CA2370739A1 - Dispositif pour diagnostics multiples de la sante de la femme - Google Patents
Dispositif pour diagnostics multiples de la sante de la femme Download PDFInfo
- Publication number
- CA2370739A1 CA2370739A1 CA002370739A CA2370739A CA2370739A1 CA 2370739 A1 CA2370739 A1 CA 2370739A1 CA 002370739 A CA002370739 A CA 002370739A CA 2370739 A CA2370739 A CA 2370739A CA 2370739 A1 CA2370739 A1 CA 2370739A1
- Authority
- CA
- Canada
- Prior art keywords
- biosensor
- absorbent article
- detect
- diagnostic device
- health
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 230000036541 health Effects 0.000 title claims abstract description 19
- 239000002250 absorbent Substances 0.000 claims abstract description 59
- 230000002745 absorbent Effects 0.000 claims abstract description 59
- 210000001124 body fluid Anatomy 0.000 claims abstract description 12
- 229910000078 germane Inorganic materials 0.000 claims abstract description 9
- 230000005186 women's health Effects 0.000 claims abstract description 3
- 239000012491 analyte Substances 0.000 claims description 44
- 229940088597 hormone Drugs 0.000 claims description 15
- 239000005556 hormone Substances 0.000 claims description 15
- 230000005906 menstruation Effects 0.000 claims description 10
- 230000016087 ovulation Effects 0.000 claims description 10
- 230000035935 pregnancy Effects 0.000 claims description 8
- 208000019802 Sexually transmitted disease Diseases 0.000 claims description 7
- 239000007788 liquid Substances 0.000 claims description 7
- 208000001132 Osteoporosis Diseases 0.000 claims description 6
- 208000015181 infectious disease Diseases 0.000 claims description 6
- 230000009245 menopause Effects 0.000 claims description 6
- 239000003792 electrolyte Substances 0.000 claims description 5
- 206010022971 Iron Deficiencies Diseases 0.000 claims description 4
- 235000003715 nutritional status Nutrition 0.000 claims description 4
- 230000002611 ovarian Effects 0.000 claims description 4
- 230000027758 ovulation cycle Effects 0.000 claims description 3
- 210000002700 urine Anatomy 0.000 abstract description 12
- 210000004914 menses Anatomy 0.000 abstract description 7
- 210000003296 saliva Anatomy 0.000 abstract description 5
- 210000004369 blood Anatomy 0.000 abstract description 4
- 239000008280 blood Substances 0.000 abstract description 4
- 210000003756 cervix mucus Anatomy 0.000 abstract description 4
- 230000006870 function Effects 0.000 description 68
- 102000004190 Enzymes Human genes 0.000 description 45
- 108090000790 Enzymes Proteins 0.000 description 45
- 229940088598 enzyme Drugs 0.000 description 45
- 230000008859 change Effects 0.000 description 37
- 239000000523 sample Substances 0.000 description 34
- 238000012360 testing method Methods 0.000 description 25
- 239000002699 waste material Substances 0.000 description 25
- 239000000463 material Substances 0.000 description 23
- 239000000758 substrate Substances 0.000 description 23
- 239000007787 solid Substances 0.000 description 22
- 102000004157 Hydrolases Human genes 0.000 description 20
- 108090000604 Hydrolases Proteins 0.000 description 20
- 241000894006 Bacteria Species 0.000 description 18
- 239000000126 substance Substances 0.000 description 18
- 239000012530 fluid Substances 0.000 description 16
- 230000004044 response Effects 0.000 description 16
- 238000000034 method Methods 0.000 description 15
- 125000006853 reporter group Chemical group 0.000 description 15
- 230000007704 transition Effects 0.000 description 15
- 230000009471 action Effects 0.000 description 14
- 150000001412 amines Chemical class 0.000 description 14
- -1 siloxanes Chemical class 0.000 description 14
- 208000004926 Bacterial Vaginosis Diseases 0.000 description 13
- 241000588724 Escherichia coli Species 0.000 description 13
- 208000037009 Vaginitis bacterial Diseases 0.000 description 13
- 238000003556 assay Methods 0.000 description 13
- 238000001514 detection method Methods 0.000 description 13
- 230000000694 effects Effects 0.000 description 13
- 230000000670 limiting effect Effects 0.000 description 12
- 230000003287 optical effect Effects 0.000 description 12
- 230000001580 bacterial effect Effects 0.000 description 11
- 206010012735 Diarrhoea Diseases 0.000 description 10
- 206010046914 Vaginal infection Diseases 0.000 description 10
- 241000700605 Viruses Species 0.000 description 10
- 241000222122 Candida albicans Species 0.000 description 8
- 241000207201 Gardnerella vaginalis Species 0.000 description 8
- 230000027455 binding Effects 0.000 description 7
- 239000010408 film Substances 0.000 description 7
- 244000000010 microbial pathogen Species 0.000 description 7
- 244000005700 microbiome Species 0.000 description 7
- 239000004005 microsphere Substances 0.000 description 7
- 208000024891 symptom Diseases 0.000 description 7
- 230000000007 visual effect Effects 0.000 description 7
- 102000035101 Aspartic proteases Human genes 0.000 description 6
- 108091005502 Aspartic proteases Proteins 0.000 description 6
- 241000702670 Rotavirus Species 0.000 description 6
- 239000003513 alkali Substances 0.000 description 6
- 239000000427 antigen Substances 0.000 description 6
- 108091007433 antigens Proteins 0.000 description 6
- 102000036639 antigens Human genes 0.000 description 6
- 230000002210 biocatalytic effect Effects 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 6
- 108091008690 chemoreceptors Proteins 0.000 description 6
- 201000010099 disease Diseases 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 244000045947 parasite Species 0.000 description 6
- 244000052769 pathogen Species 0.000 description 6
- 229920000642 polymer Polymers 0.000 description 6
- 239000010409 thin film Substances 0.000 description 6
- 239000003053 toxin Substances 0.000 description 6
- 231100000765 toxin Toxicity 0.000 description 6
- 108700012359 toxins Proteins 0.000 description 6
- 238000011282 treatment Methods 0.000 description 6
- 206010021639 Incontinence Diseases 0.000 description 5
- 239000000853 adhesive Substances 0.000 description 5
- 230000001070 adhesive effect Effects 0.000 description 5
- 244000052616 bacterial pathogen Species 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 5
- 239000012634 fragment Substances 0.000 description 5
- 239000003550 marker Substances 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 108020003175 receptors Proteins 0.000 description 5
- 102000005962 receptors Human genes 0.000 description 5
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 4
- 206010007134 Candida infections Diseases 0.000 description 4
- 241000606161 Chlamydia Species 0.000 description 4
- 102000012673 Follicle Stimulating Hormone Human genes 0.000 description 4
- 108010079345 Follicle Stimulating Hormone Proteins 0.000 description 4
- 241000233866 Fungi Species 0.000 description 4
- 102000009151 Luteinizing Hormone Human genes 0.000 description 4
- 108010073521 Luteinizing Hormone Proteins 0.000 description 4
- 102000003992 Peroxidases Human genes 0.000 description 4
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 4
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 4
- 206010040880 Skin irritation Diseases 0.000 description 4
- 241000224527 Trichomonas vaginalis Species 0.000 description 4
- 229910021417 amorphous silicon Inorganic materials 0.000 description 4
- 230000003321 amplification Effects 0.000 description 4
- 229940095731 candida albicans Drugs 0.000 description 4
- 201000003984 candidiasis Diseases 0.000 description 4
- 238000004891 communication Methods 0.000 description 4
- 229940028334 follicle stimulating hormone Drugs 0.000 description 4
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 4
- 239000011159 matrix material Substances 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 238000003199 nucleic acid amplification method Methods 0.000 description 4
- 239000002245 particle Substances 0.000 description 4
- 239000004033 plastic Substances 0.000 description 4
- 229920003023 plastic Polymers 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 239000010703 silicon Substances 0.000 description 4
- 230000036556 skin irritation Effects 0.000 description 4
- 231100000475 skin irritation Toxicity 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- 235000012431 wafers Nutrition 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 229920002799 BoPET Polymers 0.000 description 3
- 241000193163 Clostridioides difficile Species 0.000 description 3
- 108020004414 DNA Proteins 0.000 description 3
- 201000004624 Dermatitis Diseases 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- 102000002812 Heat-Shock Proteins Human genes 0.000 description 3
- 108010004889 Heat-Shock Proteins Proteins 0.000 description 3
- 241000725303 Human immunodeficiency virus Species 0.000 description 3
- 239000005041 Mylar™ Substances 0.000 description 3
- 241000607768 Shigella Species 0.000 description 3
- 101710097834 Thiol protease Proteins 0.000 description 3
- PUDCZUQFOPHIGU-UHFFFAOYSA-N [2-methyl-4-[(2-methylphenyl)diazenyl]phenyl]azanium;chloride Chemical compound Cl.C1=C(N)C(C)=CC(N=NC=2C(=CC=CC=2)C)=C1 PUDCZUQFOPHIGU-UHFFFAOYSA-N 0.000 description 3
- 238000013459 approach Methods 0.000 description 3
- 239000011111 cardboard Substances 0.000 description 3
- XBLIFEQTVVSTIM-UHFFFAOYSA-L chembl2105392 Chemical compound [Na+].[Na+].[O-]S(=O)(=O)C1=CC2=CC(S([O-])(=O)=O)=CC=C2C(O)=C1N=NC1=CC=C([N+]([O-])=O)C=C1[N+]([O-])=O XBLIFEQTVVSTIM-UHFFFAOYSA-L 0.000 description 3
- 239000007795 chemical reaction product Substances 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 238000003776 cleavage reaction Methods 0.000 description 3
- 238000011109 contamination Methods 0.000 description 3
- 239000003085 diluting agent Substances 0.000 description 3
- 241001493065 dsRNA viruses Species 0.000 description 3
- 235000013601 eggs Nutrition 0.000 description 3
- 239000010931 gold Substances 0.000 description 3
- 229910052737 gold Inorganic materials 0.000 description 3
- 238000003018 immunoassay Methods 0.000 description 3
- 229940040129 luteinizing hormone Drugs 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 230000036961 partial effect Effects 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 238000005381 potential energy Methods 0.000 description 3
- 230000001376 precipitating effect Effects 0.000 description 3
- 238000009597 pregnancy test Methods 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 108010017378 prolyl aminopeptidase Proteins 0.000 description 3
- 125000001453 quaternary ammonium group Chemical group 0.000 description 3
- 230000000246 remedial effect Effects 0.000 description 3
- 230000007017 scission Effects 0.000 description 3
- 230000035945 sensitivity Effects 0.000 description 3
- 229910052710 silicon Inorganic materials 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 229920000247 superabsorbent polymer Polymers 0.000 description 3
- 238000002198 surface plasmon resonance spectroscopy Methods 0.000 description 3
- 238000012546 transfer Methods 0.000 description 3
- 230000001960 triggered effect Effects 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical group N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- MDGFKZKMIQQRPU-UHFFFAOYSA-N 2-bromo-4-[3-(3-bromo-5-chloro-4-hydroxyphenyl)-1,1-dioxo-2,1$l^{6}-benzoxathiol-3-yl]-6-chlorophenol Chemical compound C1=C(Br)C(O)=C(Cl)C=C1C1(C=2C=C(Br)C(O)=C(Cl)C=2)C2=CC=CC=C2S(=O)(=O)O1 MDGFKZKMIQQRPU-UHFFFAOYSA-N 0.000 description 2
- JBIJLHTVPXGSAM-UHFFFAOYSA-N 2-naphthylamine Chemical compound C1=CC=CC2=CC(N)=CC=C21 JBIJLHTVPXGSAM-UHFFFAOYSA-N 0.000 description 2
- RLFWWDJHLFCNIJ-UHFFFAOYSA-N 4-aminoantipyrine Chemical compound CN1C(C)=C(N)C(=O)N1C1=CC=CC=C1 RLFWWDJHLFCNIJ-UHFFFAOYSA-N 0.000 description 2
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 2
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 2
- 239000000592 Artificial Cell Substances 0.000 description 2
- 108090001008 Avidin Proteins 0.000 description 2
- 241000606125 Bacteroides Species 0.000 description 2
- FRPHFZCDPYBUAU-UHFFFAOYSA-N Bromocresolgreen Chemical compound CC1=C(Br)C(O)=C(Br)C=C1C1(C=2C(=C(Br)C(O)=C(Br)C=2)C)C2=CC=CC=C2S(=O)(=O)O1 FRPHFZCDPYBUAU-UHFFFAOYSA-N 0.000 description 2
- 241000589875 Campylobacter jejuni Species 0.000 description 2
- 241000223935 Cryptosporidium Species 0.000 description 2
- 108090000695 Cytokines Proteins 0.000 description 2
- 102000004127 Cytokines Human genes 0.000 description 2
- 241000224467 Giardia intestinalis Species 0.000 description 2
- 241000147041 Guaiacum officinale Species 0.000 description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- 108010001336 Horseradish Peroxidase Proteins 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- 102000014150 Interferons Human genes 0.000 description 2
- 108010050904 Interferons Proteins 0.000 description 2
- 241000203736 Mobiluncus Species 0.000 description 2
- 241000204048 Mycoplasma hominis Species 0.000 description 2
- 102000004316 Oxidoreductases Human genes 0.000 description 2
- 108090000854 Oxidoreductases Proteins 0.000 description 2
- 108700020962 Peroxidase Proteins 0.000 description 2
- 239000004698 Polyethylene Substances 0.000 description 2
- 241001135215 Prevotella bivia Species 0.000 description 2
- 241000607762 Shigella flexneri Species 0.000 description 2
- 241000607760 Shigella sonnei Species 0.000 description 2
- 201000008100 Vaginitis Diseases 0.000 description 2
- 241000607626 Vibrio cholerae Species 0.000 description 2
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 2
- 125000000217 alkyl group Chemical group 0.000 description 2
- ANBBXQWFNXMHLD-UHFFFAOYSA-N aluminum;sodium;oxygen(2-) Chemical compound [O-2].[O-2].[Na+].[Al+3] ANBBXQWFNXMHLD-UHFFFAOYSA-N 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- UDSAIICHUKSCKT-UHFFFAOYSA-N bromophenol blue Chemical compound C1=C(Br)C(O)=C(Br)C=C1C1(C=2C=C(Br)C(O)=C(Br)C=2)C2=CC=CC=C2S(=O)(=O)O1 UDSAIICHUKSCKT-UHFFFAOYSA-N 0.000 description 2
- 210000000170 cell membrane Anatomy 0.000 description 2
- 210000002421 cell wall Anatomy 0.000 description 2
- 239000013626 chemical specie Substances 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 230000000112 colonic effect Effects 0.000 description 2
- 230000013872 defecation Effects 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 238000002405 diagnostic procedure Methods 0.000 description 2
- 239000002532 enzyme inhibitor Substances 0.000 description 2
- 229940011871 estrogen Drugs 0.000 description 2
- 239000000262 estrogen Substances 0.000 description 2
- XJRPTMORGOIMMI-UHFFFAOYSA-N ethyl 2-amino-4-(trifluoromethyl)-1,3-thiazole-5-carboxylate Chemical compound CCOC(=O)C=1SC(N)=NC=1C(F)(F)F XJRPTMORGOIMMI-UHFFFAOYSA-N 0.000 description 2
- 210000003608 fece Anatomy 0.000 description 2
- 230000035558 fertility Effects 0.000 description 2
- 239000006260 foam Substances 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 229940085435 giardia lamblia Drugs 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 229940091561 guaiac Drugs 0.000 description 2
- 229940047124 interferons Drugs 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 239000011325 microbead Substances 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- 229910021421 monocrystalline silicon Inorganic materials 0.000 description 2
- 210000003463 organelle Anatomy 0.000 description 2
- 239000000123 paper Substances 0.000 description 2
- 108040007629 peroxidase activity proteins Proteins 0.000 description 2
- 239000007793 ph indicator Substances 0.000 description 2
- 150000002989 phenols Chemical class 0.000 description 2
- 238000013439 planning Methods 0.000 description 2
- 229920000573 polyethylene Polymers 0.000 description 2
- 238000003752 polymerase chain reaction Methods 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 239000000186 progesterone Substances 0.000 description 2
- 229960003387 progesterone Drugs 0.000 description 2
- 230000000069 prophylactic effect Effects 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 229910001388 sodium aluminate Inorganic materials 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L sodium carbonate Substances [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 230000009870 specific binding Effects 0.000 description 2
- 230000003595 spectral effect Effects 0.000 description 2
- 230000008093 supporting effect Effects 0.000 description 2
- 210000004243 sweat Anatomy 0.000 description 2
- 230000009885 systemic effect Effects 0.000 description 2
- 230000001131 transforming effect Effects 0.000 description 2
- 230000032258 transport Effects 0.000 description 2
- 241000701161 unidentified adenovirus Species 0.000 description 2
- 206010046901 vaginal discharge Diseases 0.000 description 2
- 229940118696 vibrio cholerae Drugs 0.000 description 2
- 230000003612 virological effect Effects 0.000 description 2
- XJOSSWFCKQDYCZ-ZDUSSCGKSA-N (2S)-N-(2-methoxynaphthalen-1-yl)pyrrolidine-2-carboxamide Chemical compound COC1=CC=C2C=CC=CC2=C1NC(=O)[C@@H]1CCCN1 XJOSSWFCKQDYCZ-ZDUSSCGKSA-N 0.000 description 1
- QRXMUCSWCMTJGU-UHFFFAOYSA-L (5-bromo-4-chloro-1h-indol-3-yl) phosphate Chemical compound C1=C(Br)C(Cl)=C2C(OP([O-])(=O)[O-])=CNC2=C1 QRXMUCSWCMTJGU-UHFFFAOYSA-L 0.000 description 1
- RUFPHBVGCFYCNW-UHFFFAOYSA-N 1-naphthylamine Chemical compound C1=CC=C2C(N)=CC=CC2=C1 RUFPHBVGCFYCNW-UHFFFAOYSA-N 0.000 description 1
- ZPLCXHWYPWVJDL-UHFFFAOYSA-N 4-[(4-hydroxyphenyl)methyl]-1,3-oxazolidin-2-one Chemical compound C1=CC(O)=CC=C1CC1NC(=O)OC1 ZPLCXHWYPWVJDL-UHFFFAOYSA-N 0.000 description 1
- YRNWIFYIFSBPAU-UHFFFAOYSA-N 4-[4-(dimethylamino)phenyl]-n,n-dimethylaniline Chemical compound C1=CC(N(C)C)=CC=C1C1=CC=C(N(C)C)C=C1 YRNWIFYIFSBPAU-UHFFFAOYSA-N 0.000 description 1
- 241000607528 Aeromonas hydrophila Species 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 206010001935 American trypanosomiasis Diseases 0.000 description 1
- 206010001986 Amoebic dysentery Diseases 0.000 description 1
- 241000606124 Bacteroides fragilis Species 0.000 description 1
- 241000186000 Bifidobacterium Species 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- IAJDOIMMPXRXGM-ZDUSSCGKSA-N C1C[C@H](NC1)C(=O)C2=C(C=CC3=CC=CC=C32)NO Chemical compound C1C[C@H](NC1)C(=O)C2=C(C=CC3=CC=CC=C32)NO IAJDOIMMPXRXGM-ZDUSSCGKSA-N 0.000 description 1
- 241000589876 Campylobacter Species 0.000 description 1
- 241000589877 Campylobacter coli Species 0.000 description 1
- 102000014914 Carrier Proteins Human genes 0.000 description 1
- 108010053835 Catalase Proteins 0.000 description 1
- 102000016938 Catalase Human genes 0.000 description 1
- 102000030523 Catechol oxidase Human genes 0.000 description 1
- 108010031396 Catechol oxidase Proteins 0.000 description 1
- 208000024699 Chagas disease Diseases 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- 102000011022 Chorionic Gonadotropin Human genes 0.000 description 1
- 108010062540 Chorionic Gonadotropin Proteins 0.000 description 1
- 108090000317 Chymotrypsin Proteins 0.000 description 1
- 241001112696 Clostridia Species 0.000 description 1
- 241000193155 Clostridium botulinum Species 0.000 description 1
- 241000193468 Clostridium perfringens Species 0.000 description 1
- 241000193466 Clostridium septicum Species 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 238000000018 DNA microarray Methods 0.000 description 1
- 239000003298 DNA probe Substances 0.000 description 1
- 108020005199 Dehydrogenases Proteins 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- ZNZYKNKBJPZETN-WELNAUFTSA-N Dialdehyde 11678 Chemical compound N1C2=CC=CC=C2C2=C1[C@H](C[C@H](/C(=C/O)C(=O)OC)[C@@H](C=C)C=O)NCC2 ZNZYKNKBJPZETN-WELNAUFTSA-N 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- 241000224432 Entamoeba histolytica Species 0.000 description 1
- 241000709661 Enterovirus Species 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 206010017533 Fungal infection Diseases 0.000 description 1
- 208000018522 Gastrointestinal disease Diseases 0.000 description 1
- 241000224466 Giardia Species 0.000 description 1
- 102000053187 Glucuronidase Human genes 0.000 description 1
- 108010060309 Glucuronidase Proteins 0.000 description 1
- 102000006771 Gonadotropins Human genes 0.000 description 1
- 108010086677 Gonadotropins Proteins 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- 108010058683 Immobilized Proteins Proteins 0.000 description 1
- 206010061217 Infestation Diseases 0.000 description 1
- 102000004125 Interleukin-1alpha Human genes 0.000 description 1
- 108010082786 Interleukin-1alpha Proteins 0.000 description 1
- 108010002350 Interleukin-2 Proteins 0.000 description 1
- 108010002386 Interleukin-3 Proteins 0.000 description 1
- 108090000978 Interleukin-4 Proteins 0.000 description 1
- 108090001007 Interleukin-8 Proteins 0.000 description 1
- 108010063738 Interleukins Proteins 0.000 description 1
- 102000015696 Interleukins Human genes 0.000 description 1
- 108090000769 Isomerases Proteins 0.000 description 1
- 102000004195 Isomerases Human genes 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- IEZATIIUZVDELT-AWEZNQCLSA-N L-proline 2-naphthylamide Chemical compound C=1C=C2C=CC=CC2=CC=1NC(=O)[C@@H]1CCCN1 IEZATIIUZVDELT-AWEZNQCLSA-N 0.000 description 1
- 241001313288 Labia Species 0.000 description 1
- 241000186660 Lactobacillus Species 0.000 description 1
- 241001676635 Lepidorhombus whiffiagonis Species 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- 229910021380 Manganese Chloride Inorganic materials 0.000 description 1
- GLFNIEUTAYBVOC-UHFFFAOYSA-L Manganese chloride Chemical compound Cl[Mn]Cl GLFNIEUTAYBVOC-UHFFFAOYSA-L 0.000 description 1
- MSFSPUZXLOGKHJ-UHFFFAOYSA-N Muraminsaeure Natural products OC(=O)C(C)OC1C(N)C(O)OC(CO)C1O MSFSPUZXLOGKHJ-UHFFFAOYSA-N 0.000 description 1
- 241000187479 Mycobacterium tuberculosis Species 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- 241000714209 Norwalk virus Species 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108010013639 Peptidoglycan Proteins 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 102000045595 Phosphoprotein Phosphatases Human genes 0.000 description 1
- 108700019535 Phosphoprotein Phosphatases Proteins 0.000 description 1
- 241000223960 Plasmodium falciparum Species 0.000 description 1
- 241000606999 Plesiomonas shigelloides Species 0.000 description 1
- 206010036618 Premenstrual syndrome Diseases 0.000 description 1
- 102000001253 Protein Kinase Human genes 0.000 description 1
- 239000003391 RNA probe Substances 0.000 description 1
- 238000001069 Raman spectroscopy Methods 0.000 description 1
- 108091007187 Reductases Proteins 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- 241001354013 Salmonella enterica subsp. enterica serovar Enteritidis Species 0.000 description 1
- 241000607726 Salmonella enterica subsp. enterica serovar Heidelberg Species 0.000 description 1
- 241000531795 Salmonella enterica subsp. enterica serovar Paratyphi A Species 0.000 description 1
- 241000293871 Salmonella enterica subsp. enterica serovar Typhi Species 0.000 description 1
- 229920002684 Sepharose Polymers 0.000 description 1
- 241000607766 Shigella boydii Species 0.000 description 1
- 241000607764 Shigella dysenteriae Species 0.000 description 1
- 101710084578 Short neurotoxin 1 Proteins 0.000 description 1
- 229910052581 Si3N4 Inorganic materials 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical class O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 241001505901 Streptococcus sp. 'group A' Species 0.000 description 1
- 241000193990 Streptococcus sp. 'group B' Species 0.000 description 1
- 101710182532 Toxin a Proteins 0.000 description 1
- 108090000992 Transferases Proteins 0.000 description 1
- 102000004357 Transferases Human genes 0.000 description 1
- 208000005448 Trichomonas Infections Diseases 0.000 description 1
- 206010044620 Trichomoniasis Diseases 0.000 description 1
- 241000223109 Trypanosoma cruzi Species 0.000 description 1
- 241000287436 Turdus merula Species 0.000 description 1
- 102000003425 Tyrosinase Human genes 0.000 description 1
- 108060008724 Tyrosinase Proteins 0.000 description 1
- 108010046334 Urease Proteins 0.000 description 1
- 201000007096 Vulvovaginal Candidiasis Diseases 0.000 description 1
- 206010064899 Vulvovaginal mycotic infection Diseases 0.000 description 1
- 241000607447 Yersinia enterocolitica Species 0.000 description 1
- QCWXUUIWCKQGHC-UHFFFAOYSA-N Zirconium Chemical compound [Zr] QCWXUUIWCKQGHC-UHFFFAOYSA-N 0.000 description 1
- 229910026551 ZrC Inorganic materials 0.000 description 1
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000002390 adhesive tape Substances 0.000 description 1
- 230000004520 agglutination Effects 0.000 description 1
- 239000012615 aggregate Substances 0.000 description 1
- 125000005210 alkyl ammonium group Chemical group 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 210000004102 animal cell Anatomy 0.000 description 1
- 210000000436 anus Anatomy 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 150000004982 aromatic amines Chemical class 0.000 description 1
- 244000309743 astrovirus Species 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 108091008324 binding proteins Proteins 0.000 description 1
- 239000003181 biological factor Substances 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 239000000090 biomarker Substances 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 239000013043 chemical agent Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 229960002376 chymotrypsin Drugs 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 239000005289 controlled pore glass Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 208000031513 cyst Diseases 0.000 description 1
- 239000000412 dendrimer Substances 0.000 description 1
- 229920000736 dendritic polymer Polymers 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 231100000020 developmental retardation Toxicity 0.000 description 1
- 229910003460 diamond Inorganic materials 0.000 description 1
- 239000010432 diamond Substances 0.000 description 1
- 230000009429 distress Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 241001492478 dsDNA viruses, no RNA stage Species 0.000 description 1
- 210000005069 ears Anatomy 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 238000005538 encapsulation Methods 0.000 description 1
- 229940007078 entamoeba histolytica Drugs 0.000 description 1
- 230000000688 enterotoxigenic effect Effects 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 229920001249 ethyl cellulose Polymers 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 230000002550 fecal effect Effects 0.000 description 1
- 210000001752 female genitalia Anatomy 0.000 description 1
- 244000000050 gastrointestinal parasite Species 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 210000004392 genitalia Anatomy 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 239000002622 gonadotropin Substances 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- 238000002657 hormone replacement therapy Methods 0.000 description 1
- 239000000017 hydrogel Substances 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 150000004679 hydroxides Chemical class 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 230000003100 immobilizing effect Effects 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 208000037797 influenza A Diseases 0.000 description 1
- 208000037798 influenza B Diseases 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 229940047122 interleukins Drugs 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 229940039696 lactobacillus Drugs 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000010808 liquid waste Substances 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- VTHJTEIRLNZDEV-UHFFFAOYSA-L magnesium dihydroxide Chemical compound [OH-].[OH-].[Mg+2] VTHJTEIRLNZDEV-UHFFFAOYSA-L 0.000 description 1
- 239000000347 magnesium hydroxide Substances 0.000 description 1
- 229910001862 magnesium hydroxide Inorganic materials 0.000 description 1
- 238000007726 management method Methods 0.000 description 1
- 239000011565 manganese chloride Substances 0.000 description 1
- 235000002867 manganese chloride Nutrition 0.000 description 1
- 229940099607 manganese chloride Drugs 0.000 description 1
- 102000006240 membrane receptors Human genes 0.000 description 1
- 108020004084 membrane receptors Proteins 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 150000004780 naphthols Chemical class 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 210000000287 oocyte Anatomy 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 239000006174 pH buffer Substances 0.000 description 1
- 230000003071 parasitic effect Effects 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229910021420 polycrystalline silicon Inorganic materials 0.000 description 1
- 229920000139 polyethylene terephthalate Polymers 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 108060006633 protein kinase Proteins 0.000 description 1
- 229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 230000008521 reorganization Effects 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 229910001112 rose gold Inorganic materials 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000012898 sample dilution Substances 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 229940007046 shigella dysenteriae Drugs 0.000 description 1
- 229940115939 shigella sonnei Drugs 0.000 description 1
- 230000011664 signaling Effects 0.000 description 1
- HBMJWWWQQXIZIP-UHFFFAOYSA-N silicon carbide Chemical compound [Si+]#[C-] HBMJWWWQQXIZIP-UHFFFAOYSA-N 0.000 description 1
- 229910010271 silicon carbide Inorganic materials 0.000 description 1
- HQVNEWCFYHHQES-UHFFFAOYSA-N silicon nitride Chemical compound N12[Si]34N5[Si]62N3[Si]51N64 HQVNEWCFYHHQES-UHFFFAOYSA-N 0.000 description 1
- 229910052814 silicon oxide Inorganic materials 0.000 description 1
- 230000036559 skin health Effects 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000008279 sol Substances 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 210000005070 sphincter Anatomy 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 238000005211 surface analysis Methods 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 238000012384 transportation and delivery Methods 0.000 description 1
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical group CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 1
- 210000003812 trophozoite Anatomy 0.000 description 1
- 230000007306 turnover Effects 0.000 description 1
- 210000001215 vagina Anatomy 0.000 description 1
- 229920003169 water-soluble polymer Polymers 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
- 229940098232 yersinia enterocolitica Drugs 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/72—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood pigments, e.g. haemoglobin, bilirubin or other porphyrins; involving occult blood
- G01N33/721—Haemoglobin
- G01N33/725—Haemoglobin using peroxidative activity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/15—Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators
- A61F13/42—Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators with wetness indicator or alarm
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/15—Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators
- A61F13/45—Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators characterised by the shape
- A61F13/47—Sanitary towels, incontinence pads or napkins
- A61F13/472—Sanitary towels, incontinence pads or napkins specially adapted for female use
- A61F13/47263—Sanitary towels, incontinence pads or napkins specially adapted for female use with activating means, e.g. elastic, heat or chemical activatable means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/15—Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators
- A61F13/56—Supporting or fastening means
- A61F13/66—Garments, holders or supports not integral with absorbent pads
- A61F13/82—Garments, holders or supports not integral with absorbent pads with means for attaching to the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/15—Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators
- A61F13/84—Accessories, not otherwise provided for, for absorbent pads
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/56—Wetness-indicators or colourants
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
- G01N33/528—Atypical element structures, e.g. gloves, rods, tampons, toilet paper
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54366—Apparatus specially adapted for solid-phase testing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/15—Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators
- A61F13/84—Accessories, not otherwise provided for, for absorbent pads
- A61F2013/8473—Accessories, not otherwise provided for, for absorbent pads for diagnostic purposes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/15—Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators
- A61F13/84—Accessories, not otherwise provided for, for absorbent pads
- A61F2013/8476—Accessories, not otherwise provided for, for absorbent pads with various devices or method
- A61F2013/8479—Accessories, not otherwise provided for, for absorbent pads with various devices or method including electric or magnetic devices
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/575—Hormones
- G01N2333/59—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/84—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving inorganic compounds or pH
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Microbiology (AREA)
- Food Science & Technology (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Medicinal Chemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Analytical Chemistry (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Materials Engineering (AREA)
- Tropical Medicine & Parasitology (AREA)
- Absorbent Articles And Supports Therefor (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Orthopedics, Nursing, And Contraception (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Abstract
L'invention porte sur un dispositif pour diagnostics multiples relatifs à la santé de la femme comportant un biodétecteur capable de détecter plusieurs analytes cibles présents dans des fluides corporels recueillis sur ou à travers la peau, et révélateurs de la santé de la femme. Lesdits fluides corporels consistent en sécrétions vaginales, règles, sang, urine et salive. Le biodétecteur comporte de préférence au moins un élément de reconnaissance de plusieurs analytes biologiques. Le dispositif pour diagnostics peut s'utiliser dans un ou plusieurs articles absorbants.
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/299,399 | 1999-04-26 | ||
| US09/299,399 US6713660B1 (en) | 1998-06-29 | 1999-04-26 | Disposable article having a biosensor |
| US51748100A | 2000-03-02 | 2000-03-02 | |
| US51744100A | 2000-03-02 | 2000-03-02 | |
| US09/517,441 | 2000-03-02 | ||
| US09/517,481 | 2000-03-02 | ||
| PCT/US2000/011207 WO2000065347A2 (fr) | 1999-04-26 | 2000-04-26 | Dispositif pour diagnostics multiples de la sante de la femme |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2370739A1 true CA2370739A1 (fr) | 2000-11-02 |
Family
ID=27404650
Family Applications (5)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002370936A Abandoned CA2370936A1 (fr) | 1999-04-26 | 2000-04-26 | Articles jetables et analogues comprenant un dispositif de detection |
| CA002367588A Abandoned CA2367588A1 (fr) | 1999-04-26 | 2000-04-26 | Protege-slip dote de capteur concu pour predire le debut de la menstruation |
| CA002370739A Abandoned CA2370739A1 (fr) | 1999-04-26 | 2000-04-26 | Dispositif pour diagnostics multiples de la sante de la femme |
| CA002370502A Abandoned CA2370502A1 (fr) | 1999-04-26 | 2000-04-26 | Protections periodiques feminines jetables pourvues d'un moyen de detection du sang, en tant que capteur |
| CA002370509A Abandoned CA2370509A1 (fr) | 1999-04-26 | 2000-04-26 | Composition pour detection de sang |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002370936A Abandoned CA2370936A1 (fr) | 1999-04-26 | 2000-04-26 | Articles jetables et analogues comprenant un dispositif de detection |
| CA002367588A Abandoned CA2367588A1 (fr) | 1999-04-26 | 2000-04-26 | Protege-slip dote de capteur concu pour predire le debut de la menstruation |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002370502A Abandoned CA2370502A1 (fr) | 1999-04-26 | 2000-04-26 | Protections periodiques feminines jetables pourvues d'un moyen de detection du sang, en tant que capteur |
| CA002370509A Abandoned CA2370509A1 (fr) | 1999-04-26 | 2000-04-26 | Composition pour detection de sang |
Country Status (8)
| Country | Link |
|---|---|
| EP (5) | EP1173758A2 (fr) |
| JP (5) | JP2003517584A (fr) |
| CN (2) | CN1349562A (fr) |
| AU (5) | AU4665800A (fr) |
| BR (2) | BR0010059A (fr) |
| CA (5) | CA2370936A1 (fr) |
| MX (5) | MXPA01010946A (fr) |
| WO (5) | WO2000065084A2 (fr) |
Families Citing this family (92)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2365769A (en) | 2000-08-18 | 2002-02-27 | Secr Defence | Skin preparations containing silicon |
| US7288080B2 (en) | 2001-06-08 | 2007-10-30 | Kimberly-Clark Worldwide, Inc. | Labial pad |
| US6890325B2 (en) | 2001-06-08 | 2005-05-10 | Kimberly-Clark Worldwide, Inc. | Labial pad having a tab |
| US7115116B2 (en) | 2001-06-08 | 2006-10-03 | Kimberly-Clark Worldwide, Inc. | Labial pad having various means |
| JP4534388B2 (ja) * | 2001-06-13 | 2010-09-01 | 富士レビオ株式会社 | 経血又は膣分泌物採取器具、キット及び方法 |
| US7002054B2 (en) | 2001-06-29 | 2006-02-21 | The Procter & Gamble Company | Absorbent article having a fever indicator |
| US6921647B2 (en) * | 2001-07-19 | 2005-07-26 | Common Sense Ltd. | Secretion-monitoring article |
| JP4677597B2 (ja) | 2001-08-31 | 2011-04-27 | ユニ・チャーム株式会社 | 使い捨ておむつ |
| US7098041B2 (en) | 2001-12-11 | 2006-08-29 | Kimberly-Clark Worldwide, Inc. | Methods to view and analyze the results from diffraction-based diagnostics |
| US7102752B2 (en) | 2001-12-11 | 2006-09-05 | Kimberly-Clark Worldwide, Inc. | Systems to view and analyze the results from diffraction-based diagnostics |
| US20030118761A1 (en) | 2001-12-21 | 2003-06-26 | Kimberly-Clark Worldwide, Inc. | Elastomeric articles having improved chemical resistance |
| EP1576181B1 (fr) | 2002-01-31 | 2013-08-14 | Systagenix Wound Management IP Co. BV. | Procede de detection de bactéries pathogène dans plaies |
| US7365238B2 (en) * | 2002-02-19 | 2008-04-29 | The Procter And Gamble Company | Absorbent article having a dehydration indicator |
| DE10225943A1 (de) | 2002-06-11 | 2004-01-08 | Basf Ag | Verfahren zur Herstellung von Estern von Polyalkoholen |
| US20040015145A1 (en) | 2002-07-16 | 2004-01-22 | The Procter & Gamble Company | Absorbent article having a graphic visible through body contacting surface |
| US7994079B2 (en) | 2002-12-17 | 2011-08-09 | Kimberly-Clark Worldwide, Inc. | Meltblown scrubbing product |
| DE10309349B4 (de) * | 2003-03-03 | 2005-11-10 | Micronas Holding Gmbh | Vorrichtung zur Untersuchung eines Analyten |
| WO2004086043A1 (fr) * | 2003-03-26 | 2004-10-07 | Johnson & Johnson Medical Limited | Prediction et detection d'une infection de plaie |
| FR2855824A1 (fr) * | 2003-06-03 | 2004-12-10 | Solvay | Procede pour la fabrication d'un compose organique comprenant au moins un groupement fonctionnel oxygene |
| US7052642B2 (en) | 2003-06-11 | 2006-05-30 | Kimberly-Clark Worldwide, Inc. | Composition for forming an elastomeric article |
| US7153561B2 (en) | 2003-07-11 | 2006-12-26 | Kimberly-Clark Wordwide, Inc. | Absorbent article with graphic design thereon |
| JP2005192863A (ja) * | 2004-01-08 | 2005-07-21 | Sekisui Chem Co Ltd | 出血検知シート |
| US7514230B2 (en) * | 2004-10-22 | 2009-04-07 | Kimberly-Clark Worldwide, Inc. | Detection of trichomonas |
| US7977529B2 (en) | 2004-11-03 | 2011-07-12 | Fred Bergman Healthcare Pty Ltd. | Incontinence management system and diaper |
| CN100397080C (zh) * | 2005-03-02 | 2008-06-25 | 金车股份有限公司 | 具有免疫层析检测指示功能的卫生用品 |
| SG126797A1 (en) * | 2005-05-04 | 2006-11-29 | King Car Food Ind Co Ltd | Sanitary utensil with functions of immuno-chromatographic test and indication |
| EP1910555A2 (fr) * | 2005-07-13 | 2008-04-16 | ECI Biotech Inc. | Substrats, détecteurs et méthodes servant à évaluer des états chez la femelle |
| WO2007076483A1 (fr) * | 2005-12-22 | 2007-07-05 | Hollister Incorporated | Système de détection de paramètres physiologiques de point d'intervention |
| US20080086103A1 (en) | 2006-10-04 | 2008-04-10 | The Procter & Gamble Company | Kit including an absorbent article |
| US8044257B2 (en) | 2006-10-30 | 2011-10-25 | Kimberly-Clark Worldwide, Inc. | Absorbent article containing lateral flow assay device |
| US7846383B2 (en) | 2006-12-15 | 2010-12-07 | Kimberly-Clark Worldwide, Inc. | Lateral flow assay device and absorbent article containing same |
| US7531471B2 (en) | 2007-01-30 | 2009-05-12 | Kimberly-Clark Worldwide, Inc. | Substrate containing a deodorizing ink |
| US20080269707A1 (en) * | 2007-04-30 | 2008-10-30 | Kimberly-Clark Worldwide, Inc. | Lateral Flow Device for Attachment to an Absorbent Article |
| GB0722729D0 (en) | 2007-11-20 | 2007-12-27 | Bristol Myers Squibb Co | Diagnostic markers of wound infection |
| US9103796B2 (en) * | 2007-12-14 | 2015-08-11 | Kimberly-Clark Worldwide, Inc. | Multi-layered devices for analyte detection |
| JP5155003B2 (ja) * | 2008-04-16 | 2013-02-27 | 花王株式会社 | 吸収性物品 |
| EP2172767A1 (fr) | 2008-10-06 | 2010-04-07 | Sony Corporation | Détecteur pour analyses de thiol |
| US8101813B2 (en) | 2008-10-30 | 2012-01-24 | Kimberly-Clark Worldwide, Inc. | Training progress indicator |
| CA2749604C (fr) | 2009-01-15 | 2015-06-16 | The Procter & Gamble Company | Articles absorbants portables en deux pieces |
| DE202010017694U1 (de) | 2009-01-15 | 2012-04-24 | The Procter & Gamble Company | Wiederverwendbare Aussenabdeckung für einen Absorptionsartikel mit Zonen variierender Eigenschaften |
| EP2376044A1 (fr) | 2009-01-15 | 2011-10-19 | The Procter & Gamble Company | Articles absorbants portables réutilisables pourvus de sous-systèmes d'accrochage |
| US9387138B2 (en) | 2009-01-15 | 2016-07-12 | The Procter & Gamble Company | Reusable outer covers for wearable absorbent articles |
| BR112013000592A2 (pt) | 2010-07-22 | 2016-07-05 | Procter & Gamble | revestimento exterior para um artigo absorvente |
| US9018434B2 (en) | 2010-08-06 | 2015-04-28 | Kimberly-Clark Worldwide, Inc. | Absorbent articles with intricate graphics |
| USD656852S1 (en) | 2010-08-06 | 2012-04-03 | Kimberly-Clark Worldwide, Inc. | Wetness indicator |
| US9536720B2 (en) * | 2010-10-29 | 2017-01-03 | Atonarp Inc. | Analyzing apparatus |
| US9034593B2 (en) | 2010-11-22 | 2015-05-19 | Kimberly-Clark Worldwide, Inc. | Vaginal indicator to detect biomarkers of good health |
| US9220640B2 (en) | 2010-12-30 | 2015-12-29 | Kimberly-Clark Worldwide, Inc. | Absorbent article including two dimensional code made from an active graphic |
| US20130202499A1 (en) * | 2012-01-31 | 2013-08-08 | Kimberly-Clark Worldwide, Inc. | Composition and Sensor for Detecting Occult Blood |
| JP5982920B2 (ja) * | 2012-03-22 | 2016-08-31 | 王子ホールディングス株式会社 | 吸収性物品 |
| JP6026822B2 (ja) * | 2012-08-28 | 2016-11-16 | 花王株式会社 | 吸収性構造体及び吸収材 |
| MX348392B (es) | 2012-10-26 | 2017-06-08 | Pixie Scient Llc | Sistemas y metodos para diagnostico de la salud. |
| US9060905B2 (en) | 2013-03-08 | 2015-06-23 | The Procter & Gamble Company | Wearable absorbent articles |
| US9078789B2 (en) | 2013-03-08 | 2015-07-14 | The Procter & Gamble Company | Outer covers and disposable absorbent inserts for pants |
| US8926579B2 (en) | 2013-03-08 | 2015-01-06 | The Procter & Gamble Company | Fastening zone configurations for outer covers of absorbent articles |
| US8936586B2 (en) | 2013-03-08 | 2015-01-20 | The Procter & Gamble Company | Ergonomic grasping aids for reusable pull-on outer covers |
| US20150057632A1 (en) | 2013-08-23 | 2015-02-26 | The Procter & Gamble Company | Absorbent Article |
| US9486368B2 (en) | 2013-12-05 | 2016-11-08 | Medline Industries, Inc. | Disposable hygienic article with means for diagnostic testing |
| US20160066894A1 (en) * | 2014-03-21 | 2016-03-10 | Razzberry Inc. | Health state monitoring device |
| CA2957066C (fr) | 2014-05-11 | 2023-02-14 | Lia Diagnostics, Inc. | Dispositif de diagnostic integre souple a base de fluide |
| CN105277656B (zh) | 2014-07-01 | 2018-12-25 | 科蒙森斯公司 | 用于鉴定羊水的诊断组合物 |
| CN106999164B (zh) * | 2014-08-21 | 2023-08-22 | 古拉森斯股份有限公司 | 用于进行体液的非侵入性分析的系统和方法 |
| US10273463B2 (en) * | 2014-10-16 | 2019-04-30 | International Paper Company | Chemiluminescent wetness indicator for absorbent products |
| US10117790B2 (en) * | 2015-02-26 | 2018-11-06 | Johnson & Johnson Vision Care, Inc. | Personal hygiene product with a digital element |
| CN104720829A (zh) * | 2015-03-19 | 2015-06-24 | 御基集团有限公司 | 一种获取吸收性制品的反馈信息的方法、装置 |
| WO2016191372A1 (fr) | 2015-05-22 | 2016-12-01 | Pixie Scientific, Llc | Affichages à indicateurs pour produits contre l'incontinence |
| WO2017010800A1 (fr) * | 2015-07-13 | 2017-01-19 | (주)룬랩 | Coupe menstruelle intelligente et procédé de mesure de sang menstruel à l'aide de la coupe menstruelle intelligente |
| JP5916935B1 (ja) * | 2015-11-05 | 2016-05-11 | ユニ・チャーム株式会社 | 愛玩動物用の吸収性物品 |
| CN109069134A (zh) | 2016-03-18 | 2018-12-21 | 古拉森斯股份有限公司 | 用于诊断阴道分泌物的收集设备 |
| CN105832459B (zh) * | 2016-03-21 | 2018-05-25 | 京东方科技集团股份有限公司 | 生理调节系统、智能内裤和生理调节方法 |
| WO2017173069A1 (fr) * | 2016-03-30 | 2017-10-05 | Convatec Technologies Inc. | Détection d'infections microbiennes dans des plaies |
| KR101830701B1 (ko) * | 2016-08-24 | 2018-02-22 | 장유리 | 피임과 임신에 용이한 여성용품 |
| CN107981870A (zh) * | 2016-10-27 | 2018-05-04 | 广州悦鸿方生物科技有限公司 | 一种卫生棉条 |
| KR101960585B1 (ko) * | 2017-01-19 | 2019-03-21 | 전자부품연구원 | 하이드로젤을 포함하는 부착형 화학 센서 및 그 제조방법 |
| WO2018190527A1 (fr) * | 2017-04-10 | 2018-10-18 | 주식회사 룬랩 | Coupelle menstruelle ayant une cartouche de test sanguin |
| CN107149524A (zh) * | 2017-05-14 | 2017-09-12 | 郭宝煊 | 智能卫生棉条 |
| EP3435261A1 (fr) * | 2017-07-28 | 2019-01-30 | Bayer AG | Prévision de cycle menstruel de la femme après l'introduction d'un système de libération de substance active intra-utérin |
| CN110221049A (zh) * | 2018-03-01 | 2019-09-10 | 三六五（天津）软件科技有限公司 | 一种智能健康检测设备 |
| CN108403297A (zh) * | 2018-03-12 | 2018-08-17 | 南京理工大学 | 一种智能敷料及其制备方法 |
| JP2021531241A (ja) | 2018-06-29 | 2021-11-18 | インターナショナル・ペーパー・カンパニー | セレンテラジンの合成 |
| US11078200B2 (en) | 2018-06-29 | 2021-08-03 | International Paper Company | Synthesis of coelenterazine |
| KR102300084B1 (ko) * | 2019-11-20 | 2021-09-08 | 주식회사 더로드 | 질병 검출용 직조물 및 이를 이용한 생리용품 |
| JP7617032B2 (ja) * | 2019-12-27 | 2025-01-17 | ユニ・チャーム株式会社 | 吸収性物品、及び吸収性物品の包装体 |
| KR102241058B1 (ko) * | 2020-03-23 | 2021-04-16 | 전남대학교산학협력단 | 패드형 여성 성기능 진단기구 |
| CN111772682B (zh) * | 2020-07-10 | 2021-08-13 | 北京大学第三医院（北京大学第三临床医学院） | 预测受试者出现卵巢储备新变化年限的系统和方法 |
| CN112710653B (zh) * | 2020-12-10 | 2024-08-30 | 达州职业技术学院 | 一种快速检测潜在血渍的专用试剂及其制备方法 |
| GB2616873B (en) | 2022-03-23 | 2024-05-22 | Ide8 Ltd | Superabsorbent Polymer based Biosensor Apparatus and Methods |
| WO2024085239A1 (fr) * | 2022-10-21 | 2024-04-25 | ユニ・チャーム株式会社 | Bandelette de test pour écoulement vaginal |
| JPWO2024084726A1 (fr) * | 2022-10-21 | 2024-04-25 | ||
| WO2024176657A1 (fr) * | 2023-02-22 | 2024-08-29 | テルモ株式会社 | Dispositif de mesure de composant et procédé de mesure de composant |
| PL444280A1 (pl) * | 2023-03-31 | 2024-10-07 | Sensdx Spółka Akcyjna | Kombinatoryczne aminokwasowe sekwencje 12merowe wiążące selektywnie patogeny wywołujące waginoze bakteryjną |
| GB2633849A (en) | 2023-09-25 | 2025-03-26 | Ide8 Ltd | Biosensor apparatus and methods |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1980002596A1 (fr) * | 1979-05-16 | 1980-11-27 | G Oster | Procede de determination d'une ovulation imminente |
| US4231370A (en) * | 1979-06-18 | 1980-11-04 | The Procter & Gamble Company | Disposable diaper type garment having wetness indicator |
| DE3231288C2 (de) * | 1982-08-23 | 1984-06-28 | MEDI-PHARMA Vertriebsgesellschaft mbH, 5000 Köln | Diagnostische Vorrichtung und ihre Verwendung |
| GB8505899D0 (en) * | 1985-03-07 | 1985-04-11 | Boots Celltech Diagnostics | Assay reagents |
| GB2208712B (en) * | 1985-03-07 | 1989-07-05 | Boots Celltech Diagnostics | Improvements relating to assay reagents |
| IL84443A (en) * | 1987-11-11 | 1993-01-14 | Schoenfeld A | Vaginal tampon |
| WO1994024557A1 (fr) * | 1993-04-16 | 1994-10-27 | The United States Of America, As Represented By Th | Article et procede permettant de detecter la presence de germes pathogenes dans des matieres fecales |
| US5468236A (en) * | 1993-06-09 | 1995-11-21 | Kimberly-Clark Corporation | Disposable absorbent product incorporating chemically reactive substance |
| US5823953A (en) * | 1996-06-20 | 1998-10-20 | Roskin; Amy C. | Secretion analysis apparatus and method |
| US5792618A (en) * | 1996-09-27 | 1998-08-11 | Moss, Inc. | Liquid single-component substrates for detection or assay of horseradish peroxidase |
| BR9605451A (pt) * | 1996-10-25 | 1998-08-04 | Barreto Leonardo Claudian Paes | Conjugado absorvente indicador |
| WO1999002985A1 (fr) * | 1997-07-11 | 1999-01-21 | Rosengreen Lea T | Dispositif portable permettant de detecter du liquide amniotique |
| JP2927772B2 (ja) * | 1998-03-09 | 1999-07-28 | 株式会社大貴 | 紙おむつ |
| ID28944A (id) * | 1998-06-29 | 2001-07-19 | Procter & Gamble | Benda sekali pakai yang memiliki sensor komponen limbah tubuh |
-
2000
- 2000-04-26 MX MXPA01010946A patent/MXPA01010946A/es not_active Application Discontinuation
- 2000-04-26 CN CN 00806784 patent/CN1349562A/zh active Pending
- 2000-04-26 EP EP00930160A patent/EP1173758A2/fr not_active Withdrawn
- 2000-04-26 AU AU46658/00A patent/AU4665800A/en not_active Abandoned
- 2000-04-26 MX MXPA01010948A patent/MXPA01010948A/es not_active Application Discontinuation
- 2000-04-26 JP JP2000614036A patent/JP2003517584A/ja not_active Withdrawn
- 2000-04-26 AU AU48029/00A patent/AU4802900A/en not_active Abandoned
- 2000-04-26 CA CA002370936A patent/CA2370936A1/fr not_active Abandoned
- 2000-04-26 BR BR0010059-5A patent/BR0010059A/pt not_active IP Right Cessation
- 2000-04-26 BR BR0010058-7A patent/BR0010058A/pt not_active IP Right Cessation
- 2000-04-26 EP EP00926388A patent/EP1173618A1/fr not_active Withdrawn
- 2000-04-26 CA CA002367588A patent/CA2367588A1/fr not_active Abandoned
- 2000-04-26 MX MXPA01010949A patent/MXPA01010949A/es not_active Application Discontinuation
- 2000-04-26 CA CA002370739A patent/CA2370739A1/fr not_active Abandoned
- 2000-04-26 WO PCT/US2000/011205 patent/WO2000065084A2/fr not_active Ceased
- 2000-04-26 AU AU44924/00A patent/AU4492400A/en not_active Abandoned
- 2000-04-26 JP JP2000614037A patent/JP2002542843A/ja not_active Withdrawn
- 2000-04-26 JP JP2000614430A patent/JP2002542846A/ja not_active Withdrawn
- 2000-04-26 CA CA002370502A patent/CA2370502A1/fr not_active Abandoned
- 2000-04-26 WO PCT/US2000/011206 patent/WO2000065096A1/fr not_active Ceased
- 2000-04-26 JP JP2000614418A patent/JP2002543397A/ja not_active Withdrawn
- 2000-04-26 WO PCT/US2000/011207 patent/WO2000065347A2/fr not_active Ceased
- 2000-04-26 MX MXPA01010950A patent/MXPA01010950A/es unknown
- 2000-04-26 CA CA002370509A patent/CA2370509A1/fr not_active Abandoned
- 2000-04-26 WO PCT/US2000/011208 patent/WO2000065348A2/fr not_active Ceased
- 2000-04-26 EP EP00928414A patent/EP1173605A2/fr not_active Withdrawn
- 2000-04-26 EP EP00928415A patent/EP1173606A2/fr not_active Withdrawn
- 2000-04-26 EP EP00930161A patent/EP1173759A2/fr not_active Withdrawn
- 2000-04-26 JP JP2000614417A patent/JP2002542845A/ja not_active Withdrawn
- 2000-04-26 WO PCT/US2000/011204 patent/WO2000065083A2/fr not_active Ceased
- 2000-04-26 MX MXPA01010952A patent/MXPA01010952A/es not_active Application Discontinuation
- 2000-04-26 CN CN 00806779 patent/CN1348501A/zh active Pending
- 2000-04-26 AU AU48030/00A patent/AU4803000A/en not_active Abandoned
- 2000-04-26 AU AU46659/00A patent/AU4665900A/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2370739A1 (fr) | Dispositif pour diagnostics multiples de la sante de la femme | |
| US6436055B1 (en) | Device having diarrhea diagnostic panel | |
| US6342037B1 (en) | Device having fecal component sensor | |
| US6479727B1 (en) | Diagnostic panel | |
| US6399853B1 (en) | Disposable article having fecal component sensor | |
| US7982088B2 (en) | Disposable article having a biosensor | |
| JP2009501715A5 (fr) | ||
| WO2000000822A1 (fr) | Dispositif dote d'un detecteur de composant fecal | |
| EP2198299A2 (fr) | Dispositif diagnostic pour identifier la rupture de la membrane pendant la grossesse | |
| EP1092151B1 (fr) | Dispositif dote d'un detecteur de composant fecal | |
| TW467736B (en) | Feminine sanitary disposable article having a blood detection means as sensor | |
| KR20020000877A (ko) | 센서로서 혈액 검출 수단을 갖는 여성의 일회용 위생 제품 | |
| CA2745309A1 (fr) | Dispositif diagnostic pour identifier la rupture de la membrane pendant la grossesse |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| FZDE | Discontinued |